New Chemotherapy: Bevacizumab & Parp Inhibitors | Memorial Sloan Kettering
2015-04-14
9
New Chemotherapy: Bevacizumab & Parp Inhibitors | Memorial Sloan Kettering
Please enable JavaScript to view the
comments powered by Disqus.
Videos similaires
Memorial Sloan Kettering West Harrison | Memorial Sloan Kettering
Meet Tongue Cancer Survivor Jessica Tar | Memorial Sloan Kettering
Ovarian Cancer Risk Factors: BRCA1 & BRCA2 | Memorial Sloan Kettering
Memorial Sloan-Kettering and IBM Watson to Advance Cancer Care.mov
How Basket Trials Are Transforming Oncology | Memorial Sloan Kettering
Prostate Cancer Detection and Survival Rates | Memorial Sloan Kettering
Endometrial Cancer Treatment Options | Memorial Sloan Kettering
Meet Gynecologic Cancer Surgeon Carol Brown | Memorial Sloan Kettering
Lymphedema Exercises and Workout Guidelines | Memorial Sloan Kettering
Targeted Cancer Therapy with T-Cells | Memorial Sloan Kettering
